BLT-1
|
B412587-25mg
|
≥98% |
321673-30-7 |
25mg
|
¥ 120.9
|
现货 |
阿拉丁 |
BPR1K871
|
B412579-1mg
|
|
2443767-35-7 |
1mg
|
¥ 182.9
|
期货,请咨询 |
阿拉丁 |
BMVC-8C3O
|
B412572-25mg
|
≥98% |
1301708-12-2 |
25mg
|
¥ 6470.9
|
现货 |
阿拉丁 |
BL-918
|
B412568-5mg
|
≥99% |
2101517-69-3 |
5mg
|
¥ 925.9
|
现货 |
阿拉丁 |
BL-918
|
B412568-25mg
|
≥99% |
2101517-69-3 |
25mg
|
¥ 3614.9
|
现货 |
阿拉丁 |
Brr2抑制剂C9
|
B412565-5mg
|
≥98% |
2104030-82-0 |
5mg
|
¥ 499.9
|
现货 |
阿拉丁 |
双-PEG8-酸
|
B412492-100mg
|
≥97% |
1246189-43-4 |
100mg
|
¥ 119.9
|
现货 |
阿拉丁 |
双聚乙二醇-NHS酯
|
B412472-100mg
|
≥97% |
65869-64-9 |
100mg
|
¥ 608.9
|
现货 |
阿拉丁 |
BNC210
|
B412449-5mg
|
≥98% |
13589-06-5 |
5mg
|
¥ 123.9
|
现货 |
阿拉丁 |
BNC210
|
B412449-25mg
|
≥98% |
13589-06-5 |
25mg
|
¥ 367.9
|
现货 |
阿拉丁 |
2,6-二甲基-4-(3-甲基-1H-吲唑-5-基)-1,4-二氢吡啶-3,5-二甲腈(BAY-474)
|
B412444-5mg
|
≥98% |
1033767-86-0 |
5mg
|
¥ 128.9
|
现货 |
阿拉丁 |
2,6-二甲基-4-(3-甲基-1H-吲唑-5-基)-1,4-二氢吡啶-3,5-二甲腈(BAY-474)
|
B412444-25mg
|
≥98% |
1033767-86-0 |
25mg
|
¥ 393.9
|
现货 |
阿拉丁 |
BI-671800
|
B412421-5mg
|
≥98% |
1093108-50-9 |
5mg
|
¥ 1014.9
|
现货 |
阿拉丁 |
BI-671800
|
B412421-25mg
|
≥98% |
1093108-50-9 |
25mg
|
¥ 3575.9
|
现货 |
阿拉丁 |
BEBT-908 (CUDC-908)
|
B412417-5mg
|
|
1235449-52-1 |
5mg
|
¥ 2679.9
|
期货,请咨询 |
阿拉丁 |
BEBT-908 (CUDC-908)
|
B412417-25mg
|
|
1235449-52-1 |
25mg
|
¥ 13215.9
|
期货,请咨询 |
阿拉丁 |
BM212
|
B412397-5mg
|
≥98% |
146204-42-4 |
5mg
|
¥ 969.9
|
现货 |
阿拉丁 |
BM212
|
B412397-25mg
|
≥98% |
146204-42-4 |
25mg
|
¥ 2653.9
|
现货 |
阿拉丁 |
BP 897盐酸盐
|
B412369-5mg
|
Moligand™, ≥98% |
314776-92-6 |
5mg
|
¥ 485.9
|
现货 |
阿拉丁 |
BP 897盐酸盐
|
B412369-25mg
|
Moligand™, ≥98% |
314776-92-6 |
25mg
|
¥ 1435.9
|
现货 |
阿拉丁 |
BS-194
|
B412346-5mg
|
Moligand™, ≥98% |
1092443-55-4 |
5mg
|
¥ 2109.9
|
期货,请咨询 |
阿拉丁 |
BS-194
|
B412346-25mg
|
Moligand™, ≥98% |
1092443-55-4 |
25mg
|
¥ 5159.9
|
期货,请咨询 |
阿拉丁 |
Boc-Val-Cit-PAB-PNP
|
B412328-5mg
|
≥98% |
870487-10-8 |
5mg
|
¥ 157.9
|
现货 |
阿拉丁 |
Boc-Val-Cit-PAB-PNP
|
B412328-25mg
|
≥98% |
870487-10-8 |
25mg
|
¥ 555.9
|
现货 |
阿拉丁 |